Clinical Trial Update: Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the MedPulser electroporation system with bleomycin for cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Cancer | Phase 4 | Status: COMPLETED